About Glen Clova Scientific
Glen Clova Scientific is a company based in Glasgow (United Kingdom) founded in 2022 by John Foerster.. Glen Clova Scientific has raised $4.96 million across 1 funding round from investors including Scottish Enterprise, Norcliffe Capital and DSW Ventures. Glen Clova Scientific offers products and services including Active Biologic Drugs. Glen Clova Scientific operates in a competitive market with competitors including adMare BioInnovations, Lupus Research, Gradient, Bioassay and Advipro, among others.
- Headquarter Glasgow, United Kingdom
- Founders John Foerster
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Glen Clova Scientific Limited
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.96 M (USD)
in 1 rounds
-
Latest Funding Round
$4.96 M (USD), Seed
Apr 24, 2024
-
Investors
Scottish Enterprise
& 3 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Glen Clova Scientific
Glen Clova Scientific offers a comprehensive portfolio of products and services, including Active Biologic Drugs. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables natural antibody generation to treat chronic diseases with reduced costs.
Funding Insights of Glen Clova Scientific
Glen Clova Scientific has successfully raised a total of $4.96M through 1 strategic funding round. The most recent funding activity was a Seed round of $4.96 million completed in April 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Seed — $5.0M
-
First Round
First Round
(24 Apr 2024)
- Investors Count 4
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2024 | Amount | Seed - Glen Clova Scientific | Valuation | Norcliffe Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Glen Clova Scientific
Glen Clova Scientific has secured backing from 4 investors, including institutional and venture fund investors. Prominent investors backing the company include Scottish Enterprise, Norcliffe Capital and DSW Ventures. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital is invested in early-stage UK regional startups.
|
Founded Year | Domain | Location | |
|
Early-stage Scottish companies are supported with investment and expertise.
|
Founded Year | Domain | Location | |
|
Provides direct investments in MedTech and biotechnology firms in the UK.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Glen Clova Scientific
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Glen Clova Scientific
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Glen Clova Scientific Comparisons
Competitors of Glen Clova Scientific
Glen Clova Scientific operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as adMare BioInnovations, Lupus Research, Gradient, Bioassay and Advipro, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biopharma consulting services are provided to clients by adMare BioInnovations.
|
|
| domain | founded_year | HQ Location |
Offers consulting for drug discovery and preclinical development in healthcare.
|
|
| domain | founded_year | HQ Location |
Environmental and risk sciences consulting is offered to diverse industries.
|
|
| domain | founded_year | HQ Location |
Biological assays for pharmaceutical and chemical products are specialized in.
|
|
| domain | founded_year | HQ Location |
Provides validation, engineering, and quality services in life sciences sectors.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Glen Clova Scientific
When was Glen Clova Scientific founded?
Glen Clova Scientific was founded in 2022 and raised its 1st funding round 2 years after it was founded.
Where is Glen Clova Scientific located?
Glen Clova Scientific is headquartered in Glasgow, United Kingdom. It is registered at Glasgow, Scotland, United Kingdom.
Is Glen Clova Scientific a funded company?
Glen Clova Scientific is a funded company, having raised a total of $4.96M across 1 funding round to date. The company's 1st funding round was a Seed of $4.96M, raised on Apr 24, 2024.
What does Glen Clova Scientific do?
Developer of biologic drugs for chronic inflammatory conditions. It allows patients to form natural antibodies against harmful targets. It focuses on targeting inflammatory conditions such as senile pruritus, atopic dermatitis, eczema, and asthma.
Who are the top competitors of Glen Clova Scientific?
Glen Clova Scientific's top competitors include adMare BioInnovations, Bioassay and Gradient.
What products or services does Glen Clova Scientific offer?
Glen Clova Scientific offers Active Biologic Drugs.
Who are Glen Clova Scientific's investors?
Glen Clova Scientific has 4 investors. Key investors include Scottish Enterprise, Norcliffe Capital, DSW Ventures, and TRICAPITAL Angels.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.